Table 4.
Significant P-values according to differential expression analysis of biological pathways
| Pathway ID | Pathway name | crg | crg/lgi | crg/lgi/bfo | crg/lgi/hroa |
|---|---|---|---|---|---|
| ko04514 | Cell adhesion molecules (CAMs) | 8.03E-05 | |||
| ko05020 | Prion diseases | 8.12E-03 | 8.10E-03 | 5.95E-04 | |
| ko04610 | Complement and coagulation cascades | 1.14E-03 | 1.14E-03 | 1.84E-03 | |
| ko04330 | Notch signaling pathway | 2.51E-03 | 2.14E-03 | 4.98E-03 | |
| ko00601 | Glycosphingolipid biosynthesis - lacto and neolacto series | 2.80E-03 | 2.80E-03 | 6.23E-03 | |
| ko04974 | Protein digestion and absorption | 2.31E-02 | 2.30E-02 | 5.74E-03 | |
| ko00740 | Riboflavin metabolism | 9.46E-03 | 4.17E-02 | ||
| ko04977 | Vitamin digestion and absorption | 1.04E-02 | |||
| ko04540 | Gap junction | 1.06E-02 | 1.05E-02 | 2.37E-02 | |
| ko04978 | Mineral absorption | 1.58E-02 | 1.37E-02 | 2.49E-02 | |
| ko05150 | Staphylococcus aureus infection | 1.41E-02 | 1.41E-02 | 1.79E-02 | |
| ko00350 | Tyrosine metabolism | 6.47E-02 | 1.58E-02 | 2.49E-02 | |
| ko05130 | Pathogenic Escherichia coli infection | 2.31E-02 | 2.05E-02 | 3.60E-02 | |
| ko04512 | ECM-receptor interaction | 4.66E-02 | 2.31E-02 | 2.30E-02 | |
| ko04145 | Phagosome | 2.74E-02 | 2.44E-02 | ||
| ko00965 | Betalain biosynthesis | 2.80E-02 | |||
| ko04391 | Hippo signaling pathway - fly | 2.94E-02 | |||
| ko04210 | Apoptosis | 4.74E-02 | 3.74E-02 |
acrg: Crassostrea gigas; lgi: Lottia gigantean; hro: H. robusta; bfo: B. floridae